DASy2020 Program Book
※ About Conference Event: Dialysis Access Synergy & SoDAS Annual Conference 2020 Date: Friday 13th March – Sunday 15th March 2020 Venue: Ding Garden, 2F, Fullon Hotel Linkou, Taoyuan, Taiwan ※ Live Stream on Youtube Day 1: https://www.youtube.com/watch?v=s3RoX1HEku4 Day 2: https://www.youtube.com/watch?v=nu_F0KI7s7I Day 3: https://www.youtube.com/watch?v=OJ9XWPRTaDM ※ Website: https://www.dialysisaccesssynergy.com/ ※ Contact Person Peipei Chen Email: dasy2020.tw@gmail.com Secretariat of DASy & SoDAS Annual Conference 2020
※ About Conference
Event: Dialysis Access Synergy & SoDAS Annual Conference 2020
Date: Friday 13th March – Sunday 15th March 2020
Venue: Ding Garden, 2F, Fullon Hotel Linkou, Taoyuan, Taiwan
※ Live Stream on Youtube
Day 1: https://www.youtube.com/watch?v=s3RoX1HEku4
Day 2: https://www.youtube.com/watch?v=nu_F0KI7s7I
Day 3: https://www.youtube.com/watch?v=OJ9XWPRTaDM
※ Website: https://www.dialysisaccesssynergy.com/
※ Contact Person
Peipei Chen
Email: dasy2020.tw@gmail.com
Secretariat of DASy & SoDAS Annual Conference 2020
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Contents
1 Welcome Message
2 About Conference
3 Program
3 Day1 / Friday, 13 th March 2020
4 Day2 / Saturday, 14 th March 2020
6 Day3 / Sunday, 15 th March 2020
8 Organizing Committee and Faculty
16 Chairs / Moderators / Commentators
41 Speakers
54 Abstract / Poster
63 Acknowledgements
WELCOME MESSAGE
First of all, I’d like to extend a warm welcome and ‘thank you’ for your interest in
DASy (Dialysis Access Synergy) 2020. I recognize that your time is valuable and
I’m seriously flattered that you chose to join us for this online event. In
successive to previous DASy meetings, we had recruited many experts from
different specialties to share and discuss on their experience in the care of
dialysis access related problems.
Due to the recently tense situation of Coronavirus epidemic episodes in different
areas, we had to adopt necessary transformation of the conference event. We
had taken advantage of the modern information technology to make DASy2020
possible in a teleconference format. Although the pneumonia epidemic had
prevented the traveling of our faculty and delegates to Taiwan this year, we hope
that the internet technology will make the event as informative and fruitful for all
the cyber participants.
With the strongest backup from SoDAS (Society of Dialysis Access Specialist),
TAVAH (Taiwan Association for Vascular and Access Health) endeavors to send
you only the best content regarding access management in this unprecedented
international online event. Hopefully we are able to provide you with practical
tips you can utilize to improve your future clinical practice. With the constant
effort, all of us may provide better patient care for dialysis access worldwide.
In the meantime, I encourage all of you actively take part in the online events. I’d
love to hear from you about what you’ve heard during DASy 2020, and what
you’re interested in in future events to come. I promise we will try our best to
ponder on your precious feedback and take action in our future events.
Again, I sincerely thank you for your attention to DASy with best regards.
Po Jen Ko MD
Chairman of DASy 2020
1
ABOUT CONFERENCE
Time and Location
Date Friday 13 th March – Sunday 15 th March 2020
Venue
Ding Garden, 2F, Fullon Hotel Linkou
Registration Time 13 th March 1250-1320
14 th March 0745-0815
15 th March 0800-0830
Live Stream
Day 1: https://www.youtube.com/watch?v=s3RoX1HEku4
Day 2: https://www.youtube.com/watch?v=nu_F0KI7s7I
Day 3: https://www.youtube.com/watch?v=OJ9XWPRTaDM
Program at a Glance
Ding Garden
1320–1440 Special session
1450–1620 BD Talks – Experts meet in DASy
Day 1, 13 th March
Ding Garden
Day 2, 14 th March
0815–1000 Right access, for the right patient, at a right time and for a right reason
1000–1015 Tea break
1015–1130 How to prevent AV access failure
1140–1245 BD Lunch symposium
1255–1305 Opening ceremony
1315–1445 Unforgettable nightmare in access procedures and what I learnt from it
1445–1505 Break
1515–1630 Recorded procedures and discussion
1640–1728 Managing failing and thrombosed dialysis access
1800–2100 Faculty dinner & moderator meeting
Ding Garden
0830–0945 Innovation in vascular access
0945–1015 Tea break
1015–1100 PD access session
1110–1200 Nursing in dialysis access
1200–1230 Lunch break
1240–1340 Steal syndrome session
1350–1450 Rare AV access related complications
1450–1510 Break
1520–1620 Central vein obstruction
1620–1630 Closing remarks
2
Day 3, 15 th March
Day1 / Friday, 13 th March 2020
PROGRAM
1320-1440 Special session
Ding Garden Chair Jackie Pei Ho, Po Jen Ko
1320-1335 Patient access maintenance during coronavirus
Yu Zhu Wang
1335-1350 Impact of COVID-19 outbreak on dialysis access management in Wuhan
Fan He
1350-1405 Impact of viral outbreak on dialysis access management in Japan
Remy Li Wei Chen
1405-1415 Impact of viral outbreak on dialysis access management
Chung Cheen Chai
1415-1425 Medical conferences in times of COVID -19
Ngoh Chin Liew
1425-1440 Impact of viral outbreak on dialysis access management: Singapore context
Jackie Pei Ho
1450-1620 BD talks – Experts meet in DASy
Ding Garden Chair Po Jen Ko
Commentator Jia Ning Yue, Jimmy Wei Hwa Tan, John Chien Hwa Chang,
Ming Xi Lu, Panagiotis Kitrou
DCBs in Dysfunctional AV Access: Effectiveness and Safety
Applications of covered stent for Access: When and Where?
Strategy and treatment for Symptomatic Central Venous Stenosis (CVS)
3
Day2 / Saturday, 14 th March 2020
PROGRAM
0815-1000 Right access, for the right patient, at a right time and for a right reason
Ding Garden Chair Jackie Pei Ho, Po Jen Ko
Commentator Edward Choke, Hsu Ting Yen, Vikram Vijayan Sannasi,
Yang Dong Liu
0815-0830 Introduce new 2020 KDOQI guideline for hemodialysis access
Charmaine Lok
0830-0845 KDOQI new guideline question, answer and discussion
Charmaine Lok
0845-0900 The pathway dialysis access specialists had gone through in Japan
Akira Miyata
0900-0915 Functional success of AVF: whole process review
Jackie Pei Ho
0915-0930 How do I practice 4Rs for Taiwanese patients who need dialysis: case-based
discussion
Po Jen Ko
0930-0945 How do I practice 4Rs for Australian patients who need dialysis: case-based
discussion
Jan John Swinnen
0945-1000 How do I practice 4Rs for American patients who need dialysis: case-based
discussion
Ingemar Davidson
1000-1030 Tea break
1015-1130 How to prevent AV access failure
Ding Garden Chair John Chien Hwa Chang
Commentator Chih Chun Yang, Harvinder Raj Singh Sidhu, Ming Xi Lu,
Yin Zuo Liu
1015-1030 My surgical strategy to achieve high AV access success
Alexander Meyer
1030-1045 The surgical procedure to prevent AVF maturation failure
Masaaki Murakami
1045-1100 Transposed Basilic Vein Fistula: Experience with 239 Cases
Benjamin Leong
1100-1115 The risk factors of AV access thrombosis
Shih Ming Huang
1115-1130 Immature fistula maturation-little role for embolization
Scott Trerotola
1140-1245 BD Lunch symposium
Ding Garden Moderator John Chien Hwa Chang, Pei Wang, Po Jen Ko
1140-1210 Maintenance Solutions for Access Patency from Singapore prospective
Tan Ru Yu
1210-1240 Optimal management strategy with covered stent in dysfunctional AV access
Panagiotis Kitrou
1240-1245 Discussion
4
Day2 / Saturday, 14 th March 2020
PROGRAM
1255-1305 Opening ceremony
Ding Garden
1315-1445 Unforgettable nightmare in access procedures and what I learned from it
Ding Garden Chair Akira Miyata, Sung Yu Chu
Commentator Ahmad Rafizi Hariz, Chun Hsien Hsin, Jia Ning Yue,
Sorracha Rookkapan, Teguh Marfen
1315-1330 Rajesh Dharmaraj Babu
1330-1345 Alexander Meyer
1345-1400 Panagiotis Kitrou
1400-1415 Jan John Swinnen
1415-1430 Sung Yu Chu
1430-1445 Ngoh Chin Liew
1445-1505 Break
1515-1630 Recorded procedures and discussion
Ding Garden Chair Alexander Meyer, Ying Cheng Chen
Commentator Edward Choke, Remy Li Wei Chen, Shih Ming Huang,, Yi Ting Tsai
Endo AVF creation
Charmaine Lok
1530-1545 The usefulness of intraoperative blood flow measurement during AVF
creation as a parameter for maturation
Sang Seob Yun
1545-1600 What you don’t know about central venous stenosis
Scott Trerotola
1600-1615 The role of delicated venous stents for central venous obstruction
Tarun Grover
1615-1630 HeRO graft: experience in Chang Gung Hospital
Chun Hsien Hsin
1640-1728 Managing failing and thrombosed dialysis access
Ding Garden Chair Akira Miyata, Jimmy Wei Hwa Tan
Commentator Hong Ye, Hsuan Tzu Yang, Ngoh Chin Liew, Shih Hsien
Weng, Sorracha Rookkapan
1640-1752 The usefulness of ultrasound for vascular access management, and ultrasound
guided intervention therapy for vascular access stenosis and obstruction
Hiroaki Haruguchi
1652-1740 AV access thrombosis treatment with Angiojet
Ta Wei Su
1704-1716 Complications associating with thrombosed AVG salvage, how to prevent them?
Yang Dong Liu
1716-1728 Efficient service program to salvage thrombosed AVG in Thailand
Sorracha Rookkapan
1800-2100 Faculty dinner & moderator meeting
Fullon Hotel Linkou
5
Day3 / Sunday, 15 th March 2020
PROGRAM
0830-0945 Innovation in vascular access
Ding Garden Chair Po Jen Ko, Tarun Grover
Commentator Heng Wan, Lillian Lou Li, Sung How Sue, Sung Yu Chu,
Yang Dong Liu
0830-0845 Portable device for your HD access monitoring
Yu Wei Fang
0845-0900 Report on first clinical trial of using Sirolimus coated balloon for HD access stenosis
Tan Chieh Suai
0900-0915 Application of AI to dialysis and vascular access care
Milind Nikam
0915-0930 Drug Coating Technology in Chronic Hemodialysis Catheters and its
Applications
Chun Hsien Hsin
0930-0945 Effectiveness of combination cutting balloon and drug coated balloon
angioplasty for AVF patency
Tay Kiang Hiong
0945-1015 Tea break
1015-1100 PD access session
Ding Garden Chair Hsuan Jen Lin
Chairman Christopher Leo, Ming Xi Lu
1015-1030 Percutaneous PD Catheter Placement by nephrologist
Hsuan Jen Lin
1030-1045 Prevent Postoperative Complications after Laparosocpic CAPD Catheter
Implantation
Tsann Long Hwang
1045-1100 Treatment of PD infection and complications
Lo Man Wai
1110-1200 Nursing in dialysis access
Ding Garden Chair Jui Hsiang Lin
Commentator Alice Su, Lillian Lou Li, Nai Hua Hsiao, Pei Hsuan Chen
1110-1122 Patient centered dialysis center, what is it?
Lillian Lou Li
1122-1134 The impact of frailty on the outcomes of hemodialysis vascular accesses
Chiu Hui Chen
1134-1146 The effectiveness of physical examination for vascular access in hemodialysis
room in Chi Mei Hospital, Chiali, Taiwan
Li Hwa Tsai
1146-1158 The experience of establishing safety culture for dialysis access care in Taiwan
Tiffany Chang
1158-1200 New patient education model in PD of National Taiwan University Hospital
Yu Jun Zhan
1200-1230 Lunch break
6
Day3 / Sunday, 15th March 2020
PROGRAM
1240-1340 Steal syndrome session
Ding Garden Chair Chung Dann Kan
Commentator Hsu Ting Yen, Jimmy Wei Hwa Tan, Masaaki Murakami,
Vikram Vijayan Sannasi
1240-1255 Understanding Steal Syndrome: Causes and Prevention
Sung How Sue
1255-1310 Steal syndrome—strategies to preserve both the vascular access and the
extremity
Zheng Ya Yu
1310-1325 Surgical correction of Dialysis Access Steal Syndrome
Hiroaki Haruguchi
1325-1340 Endovascular correction of Dialysis Access Steal Syndrome
Veera Suwanruangsri
1350-1450 Rare AV access related complications
Ding Garden Chair Hsu Ting Yen, Jan John Swinnen
Commentator Benjamin Leong, Chih Chun Yang, Sang Seob Yun, Tan
Chieh Suai, Veera Suwanruangsri, Ying Cheng Chen
1350-1405 Increased mortality rates after DCB for PAD patients: Is it real and does it
affects hemodialysis patients?
Jan John Swinnen
1405-1420 A provider-initiated patient tracking systems by using A Web-Based Platform
in a vascular access referral center in China
Jia Ning Yue
1430-1445 Arm pain during hemodialysis: shunt related?
Remy Li Wei Chen
1445-1500 Rare hemodialysis catheter-related complications
Hong Ye
1450-1510 Break
1520-1620 Central vein obstruction
Ding Garden Chair Jackie Pei Ho, John Chien Hwa Chang
Commentator Ahmad Rafizi Hariz, Edward Choke, Yin Zuo Liu
1520-1535 Operation techniques and single-center follow-up result of chest wall
arteriovenous graft
Kang She
1535-1550 HeRO graft Taiwan experience
Shih Hsien Weng
1550-1605 Central vein intervention: perspectives from nephrologist
Yu Fei Wang
1605-1620 Resurrection of bare metal stent in treatment of CVS
Jimmy Wei Hwa Tan
1620-1630 Closing remarks
Ding Garden
7
Director
Chairman
Jackie Pei Ho
Singapore
Po Jen Ko
Taiwan
Organizing Committee
John Chien Hwa Chang
Taiwan
Jimmy Wei Hwa Tan
Taiwan
Ming Ju Hsieh
Taiwan
Pei Hsuan Chen
Taiwan
Shih Hsien Weng
Taiwan
Sung Yu Chu
Taiwan
8
Faculty
Ahmad Rafizi Hariz
Malaysia
Akira Miyata
Japan
Alexander Meyer
Germany
Alice Su
Taiwan
Benjamin Leong
Malaysia
Charmaine Lok
Canada
Chih Chun Yang
Taiwan
Chiu Hui Chen
Taiwan
Christopher Leo
Singapore
9
Faculty
Chun Hsien Hsin
Taiwan
Chung Cheen Chai
Singapore
Chung Dann Kan
Taiwan
Edward Choke
Singapore
Fang He
China
Harvinder Raj Singh Sidhu
Singapore
Heng Wan
China
Hiroaki Haruguchi
Japan
Hong Ye
China
10
Faculty
‘
Hsu Ting Yen
Taiwan
Hsuan Jen Lin
Taiwan
Hsuan Tzu Yang
Taiwan
Ingemar Davidson
US
Jan John Swinnen
Australia
Jia Ning Yue
China
Jui Hsiang Lin
Taiwan
Kang She
China
Li Hwa Tsai
Taiwan
11
Faculty
Lilian Lou Li
Singapore
Lo Man Wai
Hong Kong
Masaaki Murakami
Japan
Milind Nikam
Singapore
Ming Xi Lu
China
Nai Hua Hsiao
Taiwan
Ngoh Chin Liew
Malaysia
Panagiotis Kitrou
Greece
Pei Wang
China
12
Faculty
Rajesh Dharmaraj Babu
Singapore
Remy Li Wei Chen
Japan
Sang Seob Yun
Korea
Scott Trerotola
US
Shih Ming Huang
Taiwan
Sorracha Rookkapan
Thailand
Sung How Sue
Taiwan
Ta Wei Su
Taiwan
Tan Chieh Suai
Singapore
13
Faculty
Tan Ru Yu
Singapore
Tarun Grover
India
Tay Kiang Hiong
Singapore
Teguh Marfen
Indonesia
Tiffany Chang
Taiwan
Tsann Long Hwang
Taiwan
Veera Suwanruangsri
Thailand
Vikram Vijayan Sannasi
Singapore
Yang Dong Liu
China
14
Faculty
Yi Ting Tsai
Taiwan
Yin Zuo Liu
Taiwan
Ying Cheng Chen
Taiwan
Yu Fei Wang
China
Yu Zhu Wang
China
Yu Jun Zhan
Taiwan
Yu Wei Fang
Taiwan
Zheng Ya Yu
China
15
Chairs /
Moderators /
Commentators
Listed in alphabetical order of first name
16
Ahmad Rafizi Hariz
Medical Lecturer, Department of Surgery, Faculty of
Medicine, University of Malaya
Areas of Research
• 2019 – 2021 Far Infrared Therapy In Promoting Early Arteriovenous
Fistula Maturation, Co-Investigator, Private Funding, (National)
• 2019 – 2021 Salvage VS Amputate : A Mixed Cohort Review based
on WIfI Classification in Asian Population, Co-Investigator, NONE, (National)
• 2018 – 2019 Modified MALAYA technique for Endoleak Prophylaxis
in EVAR, Principal Investigator(PI), NONE, (National)
• 2017 – 2019 MALAYA technique for treatment of peripheral arterial
pseudoaneurysm, Principal Investigator(PI), NONE, (National)
Akira Miyata
Head, Clinical Department, International Medical Relief of
Kumamoto Red Cross Hospital, Kumamoto, Japan
Dr. Miyata has varies international disaster response experience. He was the
team leader of Japanese Red Cross-Emergency Response Unit for South-East
Iran earthquake in 2004, South Asia earthquake in 2005 and Chile earthquake in
2010. He also served as the team leader of Hong-Kong red cross / Japanese red
cross joint training course for the Emergency Response Unit of International Red
Cross and Red Crescent Societies in Hong Kong in 2010. Currently, He is
working as the Japanese Representative of the Asia-Pacific Medico-Legal
Association Networks for the Victims of Disasters and Terrorism.
17
Alexander Meyer
Senior Consultant, Department of General, Visceral,
Vascular Surgery and Coloproctology, Johanniter
Krankenhauses Rheinhausen
Experience
• 1999 – 2005 Chief Consultant at the Department of General, Visceral
and Vascular Surgery, Katholische Kliniken Essen-Nord-West
• 1996 – 1999 Consultant at the Department of General, Visceral and
Vascular Surgery, Katholische Kliniken Essen-Nord
• 1992 – 1995 Registrar and Senior Registrar at the Department of
General, Abdominal, Vascular and Pediatric Surgery (Prof. Dr. Feifel) and
at the Department of Traumatology (Prof. Dr. Mutschler), University Hospital
Homburg / Saar
• 1991 – 1992 Senior House Officer at the Department of General and
Abdominal Surgery, Städtisches Klinikum Fulda (Prof.Dr. K.-D. Rumpf)
Alice Su
Clinical Service Specialist, DaVita Care (Taiwan)
Private Limited
Experience
• 2016 – 2016 Deputy Head Nurse, An Ren Clinic
• 1994 – 2016 Head Nurse, Three Trust Clinic
• 1988 – 1994 Hemodialysis Nurse Leader, Chung Gung Memorial
Hospital
• 1988 – 1988 Nurse, Taipei Blood Center
18
Benjamin Leong
Consultant Vascular & Endovascular Surgeon, KPJ
Sabah Specialist Hospital, Sabah, Malaysia
Experience
• Special interest in vascular access and endovascular interventions
• Qualified as vascular surgeon in 2013 with training from Kuala Lumpur
Hospital and Royal Perth Hospital
• Set up and initiated permanent vascular surgical service in Sabah, East
Malaysia and current head of vascular surgical service in Sabah
• Course director in aortic, venous and peripheral endovascular workshops.
• Invited faculty for both local and international vascular conferences
Chih Chun Yang
Chief Director, Da Chien Health Medical System,
Department of Cardiovascular Surgery
Experience
• 2016 – 2019 Attending Medical Doctor, Tainan Municipal An-Nan
Hospital - China Medical University, Department of Cardiovascular Surgery
• 2014 – 2016 Attending Medical Doctor, Taichung Veterans General
Hospital, Chiayi branch, Department of Cardiovascular Surgery
• 2010 – 2013 Residency, cardiovascular surgery, Taichung Veterans
General Hospital, Department of Cardiovascular Surgery
• 2009 – 2010 Residency, cardiovascular surgery, Taipei Veterans General
Hospital, Department of Cardiovascular Surgery
19
Christopher Leo
Consultant, Nephrology, National University Health
System
Dr. Christopher Leo graduated from the Auckland University School of Medicine,
New Zealand. He is a Consultant Nephrologist and is a Fellow of the Academy
of Medicine (Singapore) and the Royal College of Physicians (Edinburgh). His
interest lies in dialysis access namely endovascular interventions of
haemodialysis fistulae and grafts, ultrasound assessments of vascular accesses,
peritoneal dialysis and vascular dialysis catheter procedures. He worked closely
with Dr. Jan (John) Swinnen from Westmead Hospital in Sydney (Australia) to
acquire the necessary endovascular and clinical skills to manage arteriovenous
dialysis accesses.
Chung Dann Kan
Professor, Department of Surgery, National Cheng
Kung University Hospital
Experience
• 2013 – 2018 Associate Professor, Department of Surgery, National
Cheng-Kung University Hospital
Specialties
• Cardiovascular Surgery, Cell Regeneration, Aortic stent surgery,
Bioengineering
Education
• Ph. D. Institute of Clinical Medicine, Medical College, National Cheng-Kung
University
• Doctor of Medicine, Kaohsiung Medical College, Kaohsiung, Taiwan
20
Chun Hsien Hsin
Attending Doctor, Department. of Vascular Surgery,
Chang Gung Memorial Hospital, Linkou Medical
Center
Experience
• 2013 – 2016 Fellowship of Dept. of Thoracic & Cardiovascular
Surgery, Chang Gung Memorial Hospital, Linkou medical center, Taoyuan,
Taiwan
• 2011 – 2013 Residency of Dept. of Surgery, Chang Gung Memorial
Hospital, Linkou medical center, Taoyuan, Taiwan
• 2009 – 2010 Internship of National Taiwan University Hospital, Taipei,
Taiwan
Edward Choke
Consultant Vascular and Endovascular Surgeon,
Sengkang General Hospital and Singapore General
Hospital
Dr. Edward Choke is presently a Consultant Vascular and Endovascular Surgeon
at Sengkang General Hospital and Singapore General Hospital. He graduated
with first class honours MBBS from the University of Sydney and undertook
specialist training in General and Vascular Surgery in Oxford between 2006 and
2010. In 2010 he was appointed the Clinical Lecturer/Specialist Registrar at the
vascular unit in Leicester Royal Infirmary. He received training in complex
tertiary level vascular and endovascular surgery, including complex abdominal
and thoracic aortic aneurysm repairs (open, endovascular or hybrid techniques)
and complex carotid surgery.
21
Harvinder Raj Singh Sidhu
Senior Consultant, General Surgery, Ng Teng Fong
General Hospital
Experienced in both Open and endovascular surgery. Underwent vascular
training in Singapore, New Zealand and Australia. Graduated from the Royal
College of Surgeons in Ireland in 1997.
I have been trained in both vascular and endovascular surgery. Other than my
formal training, I completed a short stint in Leipzig, Germany in 2013 in
endovascular surgery. I can perform highly complex endovascular hybrid
procedures, which include aortic and peripheral arterial work. I am also
competent in endovenous ablation therapy for varicose veins. My specialty
interest is in diabetic foot limb salvage and I am very active in renal access
surgery for patients on dialysis.
Heng Wan
Department of vascular surgery, Nanfang Hospital,
Southern Medical University
Experience
• Young member of the branch of foreign science of Guangdong Medical
Association
• Member and Secretary of hemodialysis pathway group, foreign science
branch, Guangdong Medical Association
• Expert of vascular pathway group of the second blood purification center
management committee of Guangdong Hospital Association
22
Hong Ye
Chief, Center for Blood Purification, The Second
Affiliated Hospital of Nanjing Medical University
Experience
• Deputy Chief, Center for Renal Disease, The Second Affiliated Hospital of
Nanjing Medical University
• Committee, Chinese Society Of Blood Purification Administration
• Chinese Medical Doctor Association
• Committee, China International Exchange and Promotion Association for
Medical and Healthcare
Hsuan Jen Lin
Attending Physician, Nephrology Department, Asian
University Hospital
Education
• Graduated from the School of Medicine, China Medical University
Specialties
• Electrolyte imbalance
• Chronic renal disease control
• Hemodialysis for uremia patients
23
Hsuan Tzu Yang
Fellowship, Cardiovascular Surgical Department,
Chang Gung Memorial Hospital, Taoyuan
Experience
• 2012 – 2014 Surgical Resident, Chang Gung Memorial Hospital
(CGMH), Taoyuan
• 2011 – 2012 Post Graduate Year, Chi Mei Hospital, Tainan
• 2010 – 2011 Internship of Traditional Chinese Medicine Department,
CGMH, Taoyuan
• 2009 – 2010 Internship, Chang Gung Memorial Hospital, Taoyuan
Hsu Ting Yen
Attending Physician, Division of Cardiovascular
Surgery, Chang Gung Memorial Hospital Kaohsiung
Medical Center
Experience
• 2005 – present Visiting staff, Department of Thoracic Cardiovascular
Surgery, Chang-Gung Memorial Hospital, Kaohsiung Medical Center,
Taiwan
• 2003 – 2005 Fellowship, Department of Thoracic Cardiovascular
Surgery, Chang-Gung Memorial Hospital, Kaohsiung Medical Center,
Taiwan
Education
• Kaohsiung Medical University
24
Jackie Pei Ho
Founding President of Society of Dialysis Access
Specialists SoDAS
Senior Consultant, Department of Cardiac, Thoracic
and Vascular Surgery, National University Health
System
Experience / Specialist
• 2013 – present Associate Professor (tenure), Department of Surgery,
National University of Singapore
• 2008 – present Department of Cardiac, Thoracic and Vascular Surgery,
National University Hospital
• 2008 – 2013 Assistant Professor, Department of Surgery, National
University of Singapore
Jan John Swinnen
Clinical Associate Professor, Westmead Hospital,
Australia
For 45 years, internationally respected vascular surgeon, Dr. John Swinnen, has
used his extensive skills, experience and compassion to save and better the lives
of thousands. Part of humanitarian organisation Médecins Sans Frontières /
Doctors Without Borders (MSF) since 2011, John has risked his life in some of
the world's most dangerous zones, including Eastern Congo, the
Afghanistan-Pakistan border, Yemen and Gaza.
He has performed a staggering 1,232 operations, treating more than 350
gunshot wounds, 250 bomb blast injuries, and five mass-casualty situations–
including the 2015 Houthi Siege in Yemen which saw 206 critical patients
treated by the service in six hours.
25
Jia Ning Yue
Attending Surgeon, Vascular Department in Zhongshan
Hospital Fudan University
Experience
• 2011 – 2013 Clinical fellowship, Vascular Department in Zhongshan
Hospital Fudan University
• 2009 – 2011 Research fellowship, Saint Joseph’s Translational
Research Institute, GA, USA
• 2004 – 2009 Residency on call for surgical service, Zhongshan
Hospital and Shanghai Xinhua Hospital
Jimmy, Wei Hwa Tan
Director, Surgery Department, Tainan Municipal
An-Nan Hospital, China Medical University
Experience
• 2013 – present Chief, Cardiovascular Surgery Department, Tainan
Municipal An-Nan Hospital, China Medical University and China Medical
University Beigang Hospital
• 2007 – 2013 Chief, Cardiovascular Surgery Department, Dalin
Tzu-Chi General Hospital
Specialties
• OPCAB and total artery OPCAB
• Mitral valvuloplasty
• Endovascular surgery (AV access, carotid, Venous)
26
John, Chien Hwa Chang
Director, Cardiovascular Surgery, Dalin Tzuchi General
Hospital
Experience
• 2010 – 2011 Fellowship, Angiology, Leipzig Heart Center, Leipzig,
Germany
• 2010 – 2013 Chief, Vascular Surgery, Dalin Tzuchi General Hospital,
Chiayi county, Taiwan, R.O.C.
• 2008 – 2010 Visiting Staff, Cardiac Surgery, Dalin Tzuchi general
hospital, Chiayi county, Taiwan, R.O.C.
• 2007 – 2008 Chief resident, cardiovascular surgery, National Taiwan
University Hospital, Taipei, Taiwan, R.O.C.
Jui Hsiang Lin
Nephrologist, De-Ren General Hospital
Jui Hsiang Lin is a nephrologist in De-Ren General Hospital and focus on
dialysis, renal care, plasma exchange, plasmapheresis, and secondary hypertension.
He has been practiced for more than 10 years. He passed United States medical
license examination and Taiwan medical license board exam. Many articles
have been published. He is also an instructor in medical college of National
Yang-Ming University. He won the prize for the outstanding university faculty,
scholarship program, graduate institute of clinical medicine of Taipei Medical
University, and a lot of travel grants in international meetings.
27
Lillian Lou Li
Chief Operating Officer, TAL Dialysis Centre
Lillian has 20 years of extensive experience in dialysis nursing, clinical training
and management of dialysis centre. Her strong dialysis knowledge ranges from
chronic outpatient dialysis, such as hemodialysis (HD) and peritoneal dialysis
(PD), as well as acute dialysis (CRRT, MARS, TPE) and home dialysis. In
addition to her ongoing work in the role of Mentor and Dialysis Centre Manager,
she has been involved in outpatient new dialysis centers setup, hospital based
joint venture projects and management-contract based project with Singapore
dialysis institution. Lillian believes in developing clinical leadership to improve
dialysis quality, outcomes and patient satisfaction.
Masaaki Murakami
Director, Vascular Access Center, Shizuoka General
Hospital
Experience
• 2010 – present Deputy Head, Physician, Shizuoka General Hospital
• 2005 – 2010 Resident, Shizuoka General Hospital
• 2004 – 2005 Clinical Fellow, Shizuoka General Hospital (Supervisor,
Noriko Mori, M.D.)
• 2003 – 2004 Clinical Fellow, Tokushima University (Supervisor,
Toshio Doi, M.D.)
Specialties
• Brachial artery superficialization
• Appropriate vascular access creation
28
Ming Xi Lu
Deputy Chief Physician, Department of Nephrology,
Sir Run Run Shaw Hospital Zhejiang University
School of Medicine
Experience
• 2002 – present Deputy Chief Physician, Department of Nephrology, Sir
Run Run Shaw Hospital Zhejiang University School of Medicine
Education
• 1997 – 2002 Clinical Medical, Zhejiang University School of Medicine
Nai Hua Hsiao
Nursing Department, Dalin Tzu Chi Hospital
My name is Hsiao, Nai-Hua. I am mainly engaged in the case follow and
management of A-V access, data statistics, A-V access care education for
patients, diet health care, and health education.
I hold a bachelor’s degree with a major in Nursing which was awarded to me by
Chung Hwa University of Medical Technology in Tainan in 2014.
Besides my major, I have also taken many course related to nursing care
science like Long term care program, nursing case management, nursing study
and evidence-based nursing, which have prepared me for software
programming in the field of nurse and study.
29
Ngoh Chin Liew
Consultant, Vascular Surgery, Subang Medical Center
Dr. Liew Ngoh Chin is one of the most renowned Vascular Surgery in practicing
at Subang Jaya Medical Centre of successful surgeries and his expertise lies in
the field of Vascular Surgery. Dr. Liew Ngoh Chin has achieved several
recognitions such as Vascular Surgery.
Procedure Focus
• Arteriovenous FIstula
• General surgery
• Laser Vein Surgery
• Vascular surgery
Panagiotis Kitrou
Consultant, Interventional Radiologist, Patras University
Hospital, Athens, Greece
Dr. Panagiotis M. Kitrou MD, MSc, PhD, EBIR is a Consultant Interventional
Radiologist in Patras University Hospital, Greece. His main scientific interests
are Dialysis, Peripheral Arterial Disease and Interventional Oncology. He has
published more than 40 scientific papers in peer review journal and has been
nominated the Editor’s Award for Distinguished Clinical Study in Vascular and
Interventional Radiology by JVIR in 2015 and 2017. He is a reviewer for more
than 10 peer review journals and has been a Distinguished Reviewer for Cardio
Vascular and Interventional Radiology (CVIR) in 2017. He has more than 200
lectures and presentations in international scientific meetings, symposia and
congresses around the world.
30
Pei Hsuan Chen
Head Nurse, Sixin Clinic Hemodialysis Room and
Clinical Operation Specialist
Experience
• 2020 – present Vitech Health Care Co. Nurse Director
• 2019 – present General Secretary of Taiwan Association of Vascular
and Access Health
• 2017 – 2019 Supervision and Operation Specialist, Davita Taiwan
• 2009 – 2016 Head Nurse, Anshiu clinic Davita Taiwan Hemodialysis
Room
• 2008 – 2009 Head Nurse, Ton-shiun clinic Hemodialysis Room
Pei Wang
Director, Blood Purification Center, the First Affiliated
Hospital of Zhengzhou University
Experience
• Director of Blood Purification Center of the First Affiliated Hospital of
Zhengzhou University
• Vice Director of Nephrology Institute of Zhengzhou University
• Henan Province Outstanding Youth Science and Technology Expert
• Vice president of Youth Committee of Chinese Society of Nephrology
Education
• Major in the clinical and basic research of blood purification and Vascular
Access
31
Po Jen Ko
Chairman, Taiwan Association of Vascular and
Access Health, Taiwan
Experience
• 2005 – present Assistant Professor, Vascular Surgery, Chang Gung
Memorial Hospital (CGMH), Taipei
• 2006 – present Assistant Professor, Chang Gung University
• 1994 – 1997 R1~R3 Department of Surgery, CGMH Taipei
• 1997 – 1999 Fellow, Division of Toracic & Cardiovascular Surgery,
CGMH
• 1999 – 2003 Attending staff, Section of Cardiovascular Surgery,
GCMH
Remy Li Wei Chen
Visiting Staff, Dialysis Center, Kamifukuoka General
Hospital
Experience
• 2018 – present Freelance Nephrologist (VS)
• 2016 – 2018 Chief, Hasuda Hospital, Kidney Dialysis Center
• 2014 – 2016 Deputy Director, Tokyo Next Dialysis Clinic
• 2012 – 2014 Chief, Nishi Tokyo Central Hospital, Nephrology and
Dialysis Department
• 2011 – 2012 Chief, Koganei Taiyo Hospital, Dialysis Department
• 2010 – 2011 Chief, Ageo Central Hospital, Division of Nephrology
• 2009 – 2010 Chief, Tsukuba Central Hospital, Division of Nephrology
32
Sang Seob Yun
Chief Professor, Aorto-Peripheral Vascular Center,
Seoul St. Mary's Hospital
Experience
• 2017 – 2019 Chief Professor, Cardio-Cerebro-Vascular Center, Seoul
St. Mary's Hospital
• 2016 – 2019 Chief Professor, Department of general surgery, Seoul
St. Mary's Hospital
• 2005 – 2016 Chief Director, peripheral vascular center, St Paul’s
Hospital
• 2005 – 2016 Professor, General Surgery, St Paul’s Hospital
Shih Hsien Weng
Attending Surgeon, Cardiovascular Surgery,
Landseed International Hospital
Experience
• 2012 – 2014 Attending Surgeon, Cardiovascular Surgery, Taipei
Veterans General Hospital, Taoyuan branch
• 2007 – 2013 Resident, Cardiovascular Surgery, Taipei Veterans
General Hospital
Education
• School of Medicine, China Medical University
Specialties
• Adult Cardiac Surgery
• Aortic Surgery
33
Shih Ming Huang
Attending Surgeon, Cardiovascular Surgery
Department, Dalin Tzu Chi Hospital, Buddhist Tzu
Chi Medical Foundation
Experience
• 2014 – 2014 Fellowship of Cardiovascular surgery, National Taiwan
University Hospital
• 2011 – 2014 Resident in Cardiovascular surgery, National Taiwan
University Hospital
• 2009 – 2011 Resident in Cardiovascular surgery, National Taiwan
University Hospital
• 2008 – 2008 Resident in Emergent department, Buddhist Tzu Chi
General Hospital
Sorracha Rookkapan
Clinical Instructor, Division of Body and Vascular
Interventional Radiology, Prince of Songkla University,
Hatyai
Dr. Sorracha Rookkapan, an interventional radiologist at Prince of Songkla
University, Hatyai, Songkhla, Thailand.
I finished the IR fellowship training program from Prince of Songkla University
and short course visiting fellow at Park Hospital, Leipzig, Germany
My specialty is about endovascular treatment for vascular disease including
PAD and malfunction hemodialysis access and now I work at the vascular
excellence center at Songklanagarind hospital, Prince of Songkla University
34
Sung How Sue
Chief, Department of Cardiovascular Surgery, Pojen
General Hospital
Experience
• Surgeon, Department of Surgery, Cheng Hsin General Hospital
• Lecturer, Department of Surgery, Tri-Service General Hospital
Publications
• Real-Time 3-Dimensional Transesophageal Echocardiography in the
Evaluation of Mitral and Aortic Valve Prosthetic Valve Dehiscence
• Risk Factors and Surgical Prognosis in Patients with Infra-Renal Abdominal
Aortic Aneurysms
• Clinical Application of Intraoperative Real-Time Three-Dimensional
Transesophageal Echocardiography
Sung Yu Chu
Assistant Professor, Department of Medical Imaging
and Intervention, Chang Gung Memorial Hospital
Experience
• 2012 – 2019 Lecturer, Chang Gung Memorial Hospital (CGMH),
Linkou
• 2003 – present Visiting Staff, Department of Medical Imaging and
Intervention, CGMH, Linkou
• 1999 – 2003 Residency in Department of Radiology, CGMH
35
Tan Chieh Suai
Senior Consultant, Department of Renal Medicine,
Singapore General Hospital, Singapore
Dr. Tan Chieh Suai is a senior consultant at the Department of Renal Medicine,
Singapore General Hospital. He is also a Clinical Senior Lecturer at the National
University of Singapore Yong Loo Lin School of Medicine and an adjunct
Assistant Professor at the Duke-NUS Medical School. His interest is focused on
Interventional Nephrology. On the average, the interventional suite performed
approximately 900 dialysis access related procedure each year, including
thrombolysis, angioplasty, stenting and tunneled hemodialysis catheter
procedures.
Tarun Grover
Director and In-charge Peripheral Vascular Lab,
Division of Vascular and Endovascular sciences,
Medanta - the Medicity
After being bestowed the honour of “First fellow in vascular and Endovascular
surgery” in 2003 accredited by the National Board of Examinations, Ministry of
Health and Family Welfare, Govt. of India, Dr. Tarun Grover embarked upon his
career as a fully trained Vascular & Endovascular surgeon at a busy tertiary
referral care centre in the very heart of Delhi city where he practiced for 16
years.
Currently he is the Associate Director and in-charge Peripheral vascular Lab,
The Division of Vascular & Endovascular sciences, at one of the premier Health
care institute in India- Medanta - The Medicity. His experience as a Vascular &
endovascular specialist spans for almost over 20 years now.
36
Teguh Marfen
Assistant Professor (Lektor), Surgery, Department of
Surgery, Faculty of Medicine, Universitas Padjadjaran
Experience
• 2006 – 2009 General surgeon in Cahya Kawaluyan Hospital
• 2000 – 2000 Services as Government medical doctor, as head of
primary health care in Bojong, Purwakarta, West Java
• 1999 – 1999 Services as Government medical doctor in Dili Hospital,
East Timor
Veera Suwanruangsri
Department of Surgery, Vascular and Endovascular
Unit, Maharat Nakhon Ratchasima Hospital
Experience
• 1997 – 2000 Resident Training Program of General Surgery at
Ramathibodi Hospital
• 2000 – present Practice in Department of Surgery, Maharat Nakhon
Ratchasima Hospital
• Perform a variety of operations of benign and malignant disease
• Perform open repair of AAA (>100 cases), bypass operations for PAD (>100
cases) and vascular access operations (>4,000 cases)
• Perform >300 cases of EVAR in seven years
• Perform >1,000 cases of peripheral intervention in eight years
37
Vikram Vijayan Sannasi
Senior Consultant Surgeon, Department of General
Surgery, Ng Teng Fong General Hospital
Having successfully completed the FRCS exit examinations in 2009, Adj Asst
Prof Vijayan was awarded the Certificate of Completion of Training. As part of
his post-exam fellowship year, he joined the Department of Vascular Surgery at
the Royal Perth Hospital in Western Australia, and focused on complex
endovascular and open vascular surgical management. He was exposed to a
substantial amount of vascular trauma–the result of a stint with the Western
Australian State Trauma Unit. Adj Asst Prof Vijayan is an active member of
several committees in JurongHealth, including the Patient Safety Workgroup, the
Diabetic Foot Workgroup, the Mortality & Morbidity Quality Assurance
Committee.
Yang Dong Liu
Associate Professor, Department of Vascular
Surgery, the First Affiliated Hospital, Chongqing Medical
University, China
Experience
• Vice-Chairman of the Chinese Medical Doctor Association hemodialysis
access Committee
• Vice-Chairman of the China non-public medical structure association kidney
disease dialysis Specialized Committee hemodialysis access Committee
• Vice-Chairman of the Chinese Association of Integrative Medicine Peripheral
Vascular Diseases Committee
38
Yi Ting Tsai
Chief, Division of Cardiovascular Surgery, Tri-Service
General Hospital
Experience
• 2003 – present Attending Physician, Division of Cardiovascular Surgery,
Department of Surgery, Tri-Service General Hospital
• 2016 – present Chief, Division of Cardiovascular Surgery, Tri-Service
General Hospital
• 2016 – present Associate Professor, Medicine National Defense
Medical Center, Taipei, R.O.C
Yin Zuo Liu
Chief, Cardiovascular Surgery Department, Asia
University Hospital
Experience
• 2014 – 2016 Chief of Cardiovascular Surgeon Department, Taichung
Hospital, Ministry of Health and Welfare, Taiwan
• 2010 – 2014 Cardiovascular Surgeon, Taichung Hospital, Ministry of
Health and Welfare, Taiwan
• 2009 – 2010 Cardiovascular Surgery Residency, Cheng Hsin Hospital,
Taiwan
• 2008 – 2009 Cardiovascular Surgery Residency, Kaohsiung Medical
University Hospital, Taiwan
39
Ying Cheng Chen
Chief, Department of Cardiovascular, Changhua
Christian Hospital
Experience
• Residency in Department of Surgery, National Taiwan University Hospital
• Attending Physician, Division of Cardiovascular Surgery, National Taiwan
University Hospital
Education
• School of Medicine, China Medical University
Specialties
• Da Vinci Surgical System
• Aortic Stent Graft
40
SPEAKERS
Listed in alphabetical order of first name
Charmaine Lok
Senior Scientist, Toronto General Hospital Research
Institute
Charmaine Lok is a Professor of Medicine at the Faculty of Medicine, University
of Toronto and Senior Scientist at the Toronto General Hospital Research
Institute. She is also associated with the Department of Clinical Epidemiology
and Biostatistics, Faculty of Health Sciences, McMaster University.
Research Interests
Dr. Lok is the Medical Director of both the Chronic Kidney Diseases and
Hemodialysis Vascular Access Programs at the Toronto General Hospital.
Chiu Hui Chen
Clinical Nursing Preceptor, Dialysis Center, National
Taiwan University Hospital Hsinchu Branch
Experience
• 2019 – present Director, Taiwan Nephrology Nurses Association TNNA
• 2007 – 2013 Head Nurse, Dialysis Center, National Taiwan
University Hospital Hsin-Chu Branch
• 1994 – 1999 Clinical Nursing Preceptor, Dialysis Center, Lo-Hsu
Medical Foundation Lotung Poh-Ai Hospital
• 1991 – 1993 Nurse, Surgical intensive care unit, Chang Gung
Memorial Hospital, Linkou
42
Chung Cheen Chai
Nephrologist, Division of Nephrology, Department of
Medicine, Khoo Teck Puat Hospital
I am Nephrologist in Division of Nephrology, Department of Medicine at Khoo
Teck Puat Hospital (KTPH), National Healthcare Group, Singapore. My area of
sub-specialty interest is in Interventional Nephrology. There is Visiting
Interventional Nephrologist in KTPH, and I learnt techniques and skills to
contribute to this hospital. I did my Fellowship training in advanced vascular
access management in Division of Vascular Surgery, Linkou Chang-Gung
Memorial Hospital, Taiwan.
Fan He
Associate Professor and Vice Director, Division of
Nephrology, Department of Internal Medicine, Tongji
Hospital
Experience
• 2014 – present Associate Professor and Vice Director of Division of
Nephrology, Tongji Hospital
• 2012 – 2014 Attending doctor in division of nephrology, Tongji Hospital
Research Area
CVD Complications of CKD, Hemodialysis Vascular Access.
Research Program
• The mechanism of USP20 regulated macrophage glucose metabolism and
following inflammatory storm in crescentic glomerulonephritis
43
Hiroaki Haruguchi
Director, Haruguchi Vascular Access Clinic
In our hospital, we will not only make the first shunt, but also treat and treat
various shunt troubles. Patients who have a shunt obstruction are very anxious
about whether or not the next dialysis can be performed, but our hospital will
respond well to such urgent patients. As a treatment method, we are equipped
with facilities to allow both surgery and percutaneous angioplasty with a balloon
catheter, and we will select the treatment suitable for each individual patient. In
addition, although it is basically a day-trip operation, we have partnered with
several hospitals so that patients who need hospitalization after surgery can
receive treatment with peace of mind.
Ingemar Davidson
Professor of Surgery, Division of Surgical Transplantation,
Dallas
Ingemar J.A. Davidson’s professional focus is on organ transplantation, Dialysis
Vascular Access in End Stage Renal Disease patients. He is past Professor of
Surgery, at the University of Texas Southwestern Medical Center Dallas, TX and
Medical Director Parkland’s Vascular Access Clinic. He is also the founder of
Kidney Academy, a non-profit entity dedicated to delivering quality education to
a global audience on topics related to dialysis access.
Dr. Davidson’s research and experience are reflected in books, peer reviewed
publications and proceedings. He is a current or past Reviewer for: Critical Care
Medicine, Journal for the American Society of Nephrology, Clinical Transplantation,
Kidney International, and Juvenile Diabetes Foundation-International.
44
Kang She
Peking University First Hospital
Dr. She obtained the doctor's degree of surgery from the department of
medicine of Peking University in 2015 and worked till now. Dr. She specializes in
vascular open surgery, such as surgery for hemodialysis access, varicose veins,
peripheral vascular disease, abdominal aortic aneurysm, etc.
Dr. She is particularly good at building complex arteriovenous fistula or graft for
patients with poor vessels condition. And Dr. She also has rich experience in the
management of complications of different hemodialysis accesses.
Dr. She has published many papers and obtained several national patents on
peripheral vascular disease and dialysis access.
Li Hwa Tsai
Leader, Hemodialysis Room, Chi Mei Hospital
Experience
• 2006 – 2008 Helin Clinic Hemodialysis
• 2003 – 2008 Madou Sin-Lau Hospital
• 1996 – 2006 Madou Sin-Lau Hospital
Education
• Master of Science in Nursing, Chang Gung University of Science and
Technology
• Bachelor of Science in Nursing, Hongguang Institute of Technology
45
Lo Man Wai
Associate Consultant, Department of Medicine and
Geriatrics, Kwong Wah Hospital
Experience
• 2013 – present Honorary Vascular Trainee in Department of Surgery,
Westmead Hospital, Sydney, Australia for 3 months
• 2008 – 2012 Resident Specialist in Department of Medicine and
Geriatrics in Kwong Wah Hospital and Our Lady of Maryknoll Hospital
• 2003 – 2008 Resident in Department of Medicine and Geriatrics of
Kwong Wah Hospital in higher physician training in Advanced Internal
Medicine and Nephrology. Had rotation to Intensive Care Unit and
convalescence care during training
Milind Nikam
Medical Director, Fresenius Medical Care Visiting
Consultant Interventional Nephrologist, Khoo Teck
Puat Hospital
Dr. Nikam is Senior Medical Director for FMC covering the South East Asia
region. FMC is the largest provider of dialysis services and products in
Singapore and globally.He is also a practicing interventional and general
nephrologist. He graduated in Mumbai with distinctions and a prestigious gold
medal. He then moved to the UK for training in general medicine and nephrology
(mainly in Manchester). He obtained a higher research degree (MD) from Univ.
of Manchester in dialysis vascular access, whilst also training in interventional
nephrology. He subsequently moved to Singapore and set up the advanced
vascular interventional nephrology program in the KTPH.
46
Ming Ju Hsieh
Associate Professor, Division of Thoracic and
Cardiovascular Surgery, Chang Gung Memorial
Hospital
Experience
• 2011 – present Physician Educator, Chang Gung Memorial Hospital
(CGMH)
• 2010 – present Assistant Professor, Surgery, Chang Gung University
• 2009 – present Assistant Professor, Division of Thoracic &
Cardiovascular Surgery, CGMH
• 2002 – 2004 Chief, Division of Thoracic Surgery, CGMH at Chiayi
• 2000 – present Attending Staff, Division of Thoracic Surgery, CGMH
Rajesh Dharmaraj Babu
Consultant, Department of Cardiac, Thoracic and
Vascular Surgery, National University Heart Centre
Singapore
Experienced Vascular Surgeon with a demonstrated history of working in the
hospital & health care industry. Skilled in Research, Vascular, Clinical Research,
Medical Devices, and Vascular Surgery. Strong consulting professional with a
FRCS focused in Surgery from Royal college of surgeons Edinburgh.
Dr. Rajesh is also actively involved in Undergraduate and Postgraduate teaching
at the National University Health system and is currently a Clinical Lecturer at
Yong Loo Lin School of Medicine.
47
Scott Trerotola
Stanley Baum Professor of Radiology, University of
Pennsylvania School of Medicine in Philadelphi
CVI Research Description
As an interventional radiologist I have a longstanding interest in peripheral
vascular disease. My research focus has largely been in venous disease and
hemodialysis access with a particular focus in mechanical thrombectomy. My
clinical foci (and more recently research foci as well), as pertains to
cardiovascular disease in particular, are the management of pulmonary
arteriovenous malformations either related to or unrelated to hereditary
hemorrhagic telangiectasia, as part of the HHT center here at Penn; and venous
thromboembolic disease, in particular the management of removable inferior
vena caval filters.
Ta Wei Su
Attending Staff, Vascular Surgery, Chang Gung
Memorial Hospital, Linkou Medical Center
Experience
• 2012 – 2014 Chief Resident Fellow, Division of Thoracic &
Cardiovascular Surgery, Chang Gung Memorial Hospital, Linkou Medical
center, Taiwan
• 2009 – 2012 R1~R3, Department of Surgery, Chang Gung Memorial
Hospital, Linkou Medical center, Taiwan
• 2004 – 2004 Internship, Department of Plastic Surgery, Klinikum
rechts der Isar TU Muenchen, Germany
48
Tan Ru Yu
Consultant, Department of Renal Medicine,
Singapore General Hospital
Specialties
• Renal Medicine, Interventional Nephrology
Awards
• Best Abstract Award 3rd Place, 4th Congress of Asian Pacific Society of
Dialysis Access
• Best Podium Abstract 2nd Place, Annual Scientific Meeting, American
Society of Diagnostic and Interventional Nephrology
• Best Poster Award (Education Research) SingHealth Duke-NUS Scientific
Meeting
• Service with a Heart Award, Singapore General Hospital
Tay Kiang Hiong
Head, Vascular and Interventional Radiology
Department, Singapore General Hospital
Dr. Tay is currently the Head of the Vascular and Interventional Radiology
Department and Assistant Chairman of the Radiological Sciences Division at
Singapore General Hospital. He is also the Academic Vice Chair of Clinical
Service Transformation for the Singhealth Duke NUS Radiological Sciences
Academic Clinical Program. He is Associate Professor at the Duke NUS Medical
School Singapore and at the Yong Loo Lin School of Medicine in National
University of Singapore.
49
Tiffany Chang
Manager Quality and IPC, Fresenius Medical Care
Asia Pacific
My name is Tiffany Chang. I graduated from nursing college on 1991 and work
in clinical field since then. I’m a Haemodialysis Nurse since 2005. During the
time I have completed my Nursing Diploma and I currently studying my master’s
degree major on Clinical Management at Asia University in Taichung. Be a
dialysis nurse is not my dream business, however it did inspire me to become a
better nurse than I expected. Haemodialysis treatment might look ordinary in
daily practices. It exits a lot of potential topic need to be discover for clinical staff.
Vascular access is one of the topics that need to be address and explore more.
I’m happy to be a haemodialysis nurse and I would like to contribute myself in
this field.
Tsann Long Hwang
Attending Staff, General Surgery, Chang Gung
Memorial Hospital
Tsann Long Hwang is an attending faculty and surgeon in general surgery in
Chang Gung Memorial Hospital in Taipei, Taiwan, where he is also the director
of the Pancreatic Cancer Team, and Chairman of the Committee of Enteral and
Parenteral Nutrition and Committee of Stem Cells and Tissue Engineering
Research. He is also a professor of surgery in the Chang Gung University,
College of Medicine, in Taiwan.
50
Yu Fei Wang
Attending Physician, Blood Purification Center, The
First Affiliated Hospital of Zhengzhou University
Dr. Yufei Wang is an attending physician in the Blood Purification Center of the
first affiliated hospital of Zhengzhou University. He is focusing on vascular
access of hemodialysis patients with 4 years of experience in this field.
Yu Wei Fang
Chief, Department of Nephrology, Shin Kong Wu Ho
Su Memorial Hospital
Specialties
• Hemodialysis
• Renal Transplant
• Renal Disease
• Dialysis
• Clinical Nephrology
• Peritoneal Dialysis
• Chronic Kidney Failure
51
Yu Zhu Wang
Chief, Department of Nephrology, Beijing Haidian
Section of Peking University Third Hospital
Experience
• 2005 – 2006 Associate Chief Surgeon, Department of Nephrology,
Beijing Haidian Section of Peking University Third Hospital
• 2000 – 2005 Associate Chief Surgeon, Department of Nephrology,
Peking University People’s Hospital
• 1995 – 2000 Attending Surgeon, Department of Nephrology, Peking
University People’s Hospital
• 1990 – 1995 Resident, Department of Nephrology, Peking University
People’s Hospital
Yu Jun Zhan
Registered Nurse, Peritoneal Dialysis Center of
National Taiwan University Hospital
Experience
• 2014 – present Registered nurse, Peritoneal Dialysis Center of National
Taiwan University Hospital
• 2009 – 2014 Registered nurse, Hemodialysis Center of National
Taiwan University Hospital
• 2004 – 2009 Registered nurse, medical ICU of National Taiwan
University Hospital
52
Zheng Ya Yu
Director, Department of General Surgery and
Vascular Surgery, Beijing Tongren Hospital, Capital
Medical University
Prof Zheng Ya Yu is a vascular and endovascular surgeon working in
department of vascular surgery, Beijing Tongren Hospital, Capital Medical
University. He graduated from University Duisburg-Essen School of Medicine,
Germany (MD). He received training in both open surgery and endovascular
intervention for Vascular Surgery in PUMC Hospital, Beijing China. He
completed his postdoctoral training in The Johns Hopkins University School of
Medicine, USA and in The Cleveland Clinic Foundation, USA from 2000-2001.
53
54
Name: Mr. Benjamin Lim
Abstract (Introduction, Methods, Results, Discussion)*
Background and Objectives
Arteriovenous grafts (AVG) are commonly used for haemodialysis access. Graft
thrombosis is one of the common complications arising from the use of AVGs, and can
lead to significant patient morbidity. Several modalities such as percutaneous thrombolysis,
or open surgical thrombectomy can be used for graft salvage. The purpose of this study is
to retrospectively compare outcomes between surgical thrombectomy and percutaneous
thrombolysis for the salvage of thrombosed upper limb AVGs.
Methods
A retrospective review of all patients who underwent salvage of thrombosed AVGs from
January 2014 to December 2018 was performed. Electronic medical records were
reviewed and data pertaining to patient demographics, comorbidities, AVG characteristics,
prior AVG interventions, current AVG intervention and procedural outcomes were collected.
Data analysis was performed using SPSS version 23. Dichotomous outcomes were
represented in percentages and compared using the independent T-test, whilst
continuous outcomes were represented in mean and compared using the Chi-square test.
Time to event outcome measures such as the 12-months primary and secondary patency
rates were represented as Kaplan-Meier curves and compared using the Log-rank test.
Multivariate analysis was further performed using the Cox regression model to adjust for
covariates. P values of less than 0.05 were taken to be statistically significant.
Results
A total of 222 salvage procedures (112 open thrombectomy and 110 percutaneous
thrombolysis) was performed. There were no significant differences between patient
demographics, antiplatelet and anticoagulation use, and graft characteristics. There was
no difference in procedural success rates (93.8% vs. 91.8%, p=0.578), or post-procedural
complications such as bleeding (3.6% vs. 2.7%, p=0.719), surgical site infection (2.6% vs.
1.8%, p=0.666). There was a trend towards more distal embolism in patients who
underwent percutaneous thrombolysis compared to open thrombectomy (2.7% vs. 8.2%,
p=0.070), although this was statistically not significant. There was also no difference in
the 12-month primary patency (log-rank 0.42) and secondary patency rates (log-rank 0.59)
between both group of patients.
Conclusion
The outcomes of open thrombectomy and percutaneous thrombolysis for salvage of
thrombosed upper limb AVGs are comparable, although there seems to be a trend
towards higher rates of distal embolism in patients who underwent percutaneous
thrombolysis.
55
56
57
Name: Dr. Lenny Suryani Safri
Abstract (Introduction, Methods, Results, Discussion)*
Methodology
This is a retrospective cohort study done in a single centre. Included were symptomatic
central venous obstructions' patients with positive central venogram following
arteriovenous fistula surgery. The end of the follow up was fixed at one year after CVO was
detected.
Result
Out of 89 patients who had positive central venogram, only 42 patients were identified as
first occurrence. Of the 42 patients; 45.2% were aged >65 years, 85.7% were diabetic,
95.2% were hypertensive, and 26.2% had hyperlipidemia. Total of 16 patients (38.1%)
developed mild central venous occlusion. 5 patients (11.9%) had severe central venous
stenosis and the remaining were classified as total occlusion of central veins. The primary
patency rates calculated according to survival analysis were 73% during the first 3 months
and 42% at one year. Bivariate analysis revealed that the factor affecting the primary
patency rate of AVF is left brachiocephalic vein lesion (P=0.034). However, there were no
other significant differences between the demographic factor (gender, age) and clinical
factors (comorbids, habit, antiplatelet usage, steroid usage, indwelling central venous
catheter) in relation to the CVO severity and the primary patency rate of AVF (P>0.05).
Discussion
The AVF patency, CVO severity and the contributing factors help in determining the
high-risk population to develop CVO that may eventually cause vascular access failure.
Our study showed that patients who develop CVO had the primary patency rate of 73%
during the first 3 months, 56% at 4th to 6th month and 41% at one year. We found a factor
that significantly decreases the primary patency: CVO at left brachiocephalic fistula
(P=0.034). The secondary patency rate was 78% during the first 3 months, 76% at 4th to
6th month and 66% at one year. The primary and secondary patency rates in our setting
were found to be lower in comparison to those reported by other authors . We postulated
that this could be due to the generally smaller veins size in our population that are known
to effect AVF patency.
In our study, demographic factors such age and gender did not influence the AVF patency
rate and CVO severity. Additional to this, we also found that the patients' comorbidities did
not have a significant effect on both outcomes. Other studies showed that diabetes
mellitus has significant correlation with AVF patency. However, in our study, we found no
significant correlations between diabetes mellitus with the AVF patency. This may be due
to proper optimization of glycemic control in our diabetes patients.
Conclusion
Central venous obstruction is a common problem occurring in patients with history of
indwelling central venous catheter. Location of lesion at the left brachiocephalic vein are
shown to have significant association with primary patency rate of fistula (P<0.05)
58
Name: Dr. Qi Tian Teo
Abstract (Introduction, Methods, Results, Discussion)*
Single-Institution experience with Surfacer, an inside-out device, together with HeRO graft
for salvage of vascular access in the challenging patient
The Surfacer Inside-Out Access Catheter System (Surfacer) is a novel approach to restore
access in central venous complete total occlusions (CTO). We report a series of 3 cases
from November 2018 to December 2019 in our institution where this technique was used
in tandem with Hemodialysis Reliable Outflow (HeRO) graft for salvage of vascular access
in patients with central CTO.
The Surfacer device is a stiff cannula loaded onto a 180cm long guidewire with a sharp tip
and deflectable needle guide. It is introduced through an 8Fr sheath in the femoral vein to
the level of occlusion. Under fluoroscopic guidance, the trajectory of the needle guide is
aligned with the target skin exit site. The sharp recanalization wire is advanced through the
needle guide and exteriorised. Using the established through-and-through wire access, a
peel-away sheath is introduced across the occlusion. A graft is then anastomosed to the
brachial artery or a pre-existing arterialised fistula. Angioplasty of the SVC is performed
followed by insertion of the venous outflow component (VOC) which is then connected to
the graft using a SuperHeRO adapter.
All 3 patients had failed prior conventional attempts at CTO crossing and had exhausted
most conventional vascular access methods. Patients B and C were already on femoral
catheters and patient A had recurrent CTO despite multiple interventions. The above
technique yielded a 100% success rate with mean operative time of 140 minutes (A=98,
B=119, C=205). Cannulation rate was 100% with all undergoing successful early
cannulation by post-operative day 3 (A=1, B=2, C=3). Post-operative complication was
seen in patient A who developed a hematoma from cannulation on POD7 requiring
evacuation. Post-operative thrombosis rate was 33% with patient B having a partially
thrombosed graft 3 months post-operatively requiring thrombolysis. No subsequent
access interventions were required for patients A and C. All vascular access remained in
use up to the time of writing with the longest dwell time of 9 months in patient A.
The Surfacer device used together with HeRO graft is a feasible technique to avoid
catheter femoral dependence in patients where conventional attempts to cross the central
CTO have failed.
59
Name: Dr. Rajendra Prasad Basavanthappa
Abstract (Introduction, Methods, Results, Discussion)*
Single Stage Basilic Vein Transposition - An Effective and Viable Autogenous Access for
Dialysis
Introduction
The National Kidney Foundation’s / Kidney Disease Outcomes Quality Initiative
recommends autogenous arteriovenous fistulas (AVF) as the preferred method for long
term hemodialysis access. Basilic vein transposition is an alternative in patients with failed
AV access. Several studies have shown better patency rates, cost-effectiveness and
fewer complications of autogenous access over prosthetic arteriovenous grafts.
Aims
To analyze patency, complication rates and outcomes of single stage basilic vein
transposition.
Materials & Methods
A single-center retrospective non-randomized study conducted in MS Ramaiah medical
college, Bangalore from Jan 2015 to December 2018. A total of 72 consented patients who
underwent single stage basilic vein transposition were included in the study. All the
surgeries were done in a single stage under regional anesthesia. All the complications,
patency rates were calculated at the end of 1 year. Statistical analysis was performed
using the Chi-square test and patency rates assessed using the Kaplan Meir survival
curve.
Results
A total of 72 single-stage BVT was performed. 44 patients had a previous failed forearm
autogenous access and 28 had either absent or thrombosed cephalic vein in the arm. The
mean age was 56.6yrs with 59.57% males. The mean basilic vein and brachial artery
diameter were 3.6mm and 3.8mm respectively. The primary patency rate at 1 year was
84%. Edema and thrombosis were the most common complication in our study.
Discussion
Single-stage basilic vein transposition is a feasible surgical option in end-stage renal
disease patients and provides durable autogenous access with reasonable patency and
fewer complication rates.
60
Name: Dr. Reuban D'cruz
Abstract (Introduction, Methods, Results, Discussion)*
Introduction
Stents are commonly deployed during endovascular maintenance or salvage of
dysfunctional haemodialysis access. Indications for stenting include immediate or early
lesion recoil or access perforation. In this study, we aim to investigate the effect of residual
lesion waisting on early outcomes after stenting.
Methods
A retrospective review of all endovascular procedures for the purpose of dialysis access
maintenance and salvage from 1st January 2016 to 30th June 2018 performed in a single
tertiary hospital was conducted. Patients who had stenting performed in the same
procedure after balloon angioplasty for the treatment of an occlusive or stenotic lesion
were identified. Electronic medical records were reviewed and relevant data such as
patient demographics and haemodialysis access characteristics were extracted. The
primary endpoint was freedom from clinically driven target lesion revascularization at
12-months (CD-TLR). Angiographic images were reviewed and patients were stratified
based on the presence of complete lesion effacement or residual lesion waisting after
balloon angioplasty prior to stent deployment. Statistical analysis was performed using
SPSS version 23.
Results
Stenting after balloon angioplasty was performed for a total of 31 patients. Univariate
analysis demonstrated that freedom from CD-TLR at 12-months for patients with
complete lesion effacement is significantly higher at 40.9%, as compared to 11.1% if there
is residual lesion waisting after balloon angioplasty (p=0.009, log-rank test). Multivariate
analysis using Cox regression accounting for potential confounders such as access type
and stent type showed that complete balloon effacement was associated with a trend to
higher freedom from CD-TLR at 12 months (HR 2.3; 95% CI 0.85-6.45; p=0.099).
Conclusions
Stent deployment should ideally be performed when complete balloon effacement of the
stenotic lesion can be achieved to ensure good outcomes. Stenting in the presence of
residual stenosis, as manifested by persistent balloon waisting, is associated with
increased re-interventions.
61
Name: Dr. Reuban D'cruz
Abstract (Introduction, Methods, Results, Discussion)*
Short-term outcomes of surgical residents compared with attending surgeons in the
creation of autogenous haemodialysis arteriovenous fistulae
Reuban D'cruz, Benjamin JH Lim, Andrew MTL Choong, Jun Jie Ng
Introduction
Hands on surgical training is important in the training and nurturing of young surgical
residents. However, there is still ongoing debate about the influence of experience or
seniority on surgical outcomes. In this study, we aim to evaluate the short-term outcomes
between surgical residents and attending surgeons in the creation of autogenous
haemodialysis arteriovenous fistulae (AVF).
Methods
A retrospective review of all patients who underwent upper limb AVF creation in a 3-year
period from 2016 to 2018 was performed. Electronic medical records were accessed and
reviewed. Patients were stratified into two groups according to the status of the main
operative surgeon, and comparison of patient demographics, operative time and AVF
maturation parameters were performed.
Results
A total of 590 AVF created from 1st January 2016 to 31st December 2018 were included in
this study. The majority of AVF were created by experienced surgeons (N=434, 73.6%),
whereas the rest were created by surgical residents under direct supervision of the
attending surgeons (N=156, 26.4%). There were no differences in patient demographics.
Surgical residents had a significantly longer operative time as compared to attending
surgeons (72.4 mins vs. 66.1 mins, 95% C.I. -10.9 to -1.7, P = 0.007). However, between
surgical residents and attending surgeons, there was no difference in the proportion of
fistulas that have successfully matured within 6 months (75.7% vs. 72.7%, P=0.447), and
no difference in the average time to maturation (105 days vs. 101 days, 95% C.I. -18.9 to
10.0, P = 0.542).
Conclusions
There is no difference in short-term maturation outcomes in the creation of autogenous
haemodialysis by surgical residents or attending surgeons, although the operative time
taken for surgical residents was significantly longer.
62
ACKNOWLEDGEMENTS
Sponsors
63
ACKNOWLEDGEMENTS
Sponsors
信 興 豐 科 技 股 份 有 限 公 司
Promedics Technology Co., Ltd
Government Sponsors
64